Wasan KM - Search Results

1

Changes in serum lipids, independent of weight, are associated with changes in symptoms during long-term clozapine treatment.

Procyshyn RM, Wasan KM, Thornton AE, Barr AM, Chen EY, Pomarol-Clotet E, Stip E, Williams R, Macewan GW, Birmingham CL, Honer WG; Clozapine and Risperidone Enhancement Study Group. Procyshyn RM, et al. Among authors: wasan km. J Psychiatry Neurosci. 2007 Sep;32(5):331-8. J Psychiatry Neurosci. 2007. PMID: 17823649 Free PMC article. Clinical Trial.

2

Clozapine alone versus clozapine and risperidone with refractory schizophrenia.

Honer WG, Thornton AE, Chen EY, Chan RC, Wong JO, Bergmann A, Falkai P, Pomarol-Clotet E, McKenna PJ, Stip E, Williams R, MacEwan GW, Wasan K, Procyshyn R; Clozapine and Risperidone Enhancement (CARE) Study Group. Honer WG, et al. N Engl J Med. 2006 Feb 2;354(5):472-82. doi: 10.1056/NEJMoa053222. N Engl J Med. 2006. PMID: 16452559 Free article. Clinical Trial.

3

Competitive displacement of clozapine from plasma proteins in normolipidemic and hyperlipidemic plasma samples: clinical implications.

Procyshyn RM, Ho T, Wasan KM. Procyshyn RM, et al. Among authors: wasan km. Drug Dev Ind Pharm. 2005 May;31(4-5):331-7. doi: 10.1081/ddc-54305. Drug Dev Ind Pharm. 2005. PMID: 16093198

4

Effect of hypertriglyceridemia on the pharmacokinetics and blood-brain barrier penetration of clozapine and norclozapine following administration to rats.

Gershkovich P, Sivak O, Sharma A, Barr AM, Procyshyn R, Wasan KM. Gershkovich P, et al. Among authors: wasan km. Eur Neuropsychopharmacol. 2010 Aug;20(8):545-52. doi: 10.1016/j.euroneuro.2010.01.002. Epub 2010 Feb 16. Eur Neuropsychopharmacol. 2010. PMID: 20163937

5

Plasma protein and lipoprotein distribution of clozapine.

Procyshyn RM, Kennedy NB, Marriage S, Wasan KM. Procyshyn RM, et al. Among authors: wasan km. Am J Psychiatry. 2001 Jun;158(6):949-51. doi: 10.1176/appi.ajp.158.6.949. Am J Psychiatry. 2001. PMID: 11384905

6

The influence of dyslipidemia on the plasma protein and lipoprotein distribution of haloperidol.

Procyshyn RM, Tsai G, Wasan KM. Procyshyn RM, et al. Among authors: wasan km. Eur Neuropsychopharmacol. 2003 Jan;13(1):33-7. doi: 10.1016/s0924-977x(02)00078-0. Eur Neuropsychopharmacol. 2003. PMID: 12480120

7

Determination of clozapine and its metabolite, norclozapine in various biological matrices using high-performance liquid chromatography.

Rosland M, Szeto P, Procyshyn R, Barr AM, Wasan KM. Rosland M, et al. Among authors: wasan km. Drug Dev Ind Pharm. 2007 Oct;33(10):1158-66. doi: 10.1080/03639040701484338. Drug Dev Ind Pharm. 2007. PMID: 17963117

8

The effects of competitive displacement on haloperidol's plasma distribution in normolipidemic and hyperlipidemic plasma.

Procyshyn RM, Ho T, Wasan KM. Procyshyn RM, et al. Among authors: wasan km. Drug Dev Ind Pharm. 2005 Oct;31(9):901-5. doi: 10.1080/03639040500272058. Drug Dev Ind Pharm. 2005. PMID: 16306002

9

Lipid concentrations in postmenopausal women on letrozole after 5 years of tamoxifen: an NCIC CTG MA.17 sub-study.

Wasan KM, Goss PE, Pritchard PH, Shepherd L, Tu D, Ingle JN. Wasan KM, et al. Breast Cancer Res Treat. 2012 Dec;136(3):769-76. doi: 10.1007/s10549-012-2294-z. Epub 2012 Oct 23. Breast Cancer Res Treat. 2012. PMID: 23089983 Clinical Trial.

10

Disodium Ascorbyl Phytostanyl Phosphates (FM-VP4) reduces plasma cholesterol concentration, body weight and abdominal fat gain within a dietary-induced obese mouse model.

Looije NA, Risovic V, Stewart DJ, Debeyer D, Kutney J, Wasan KM. Looije NA, et al. Among authors: wasan km. J Pharm Pharm Sci. 2005 Aug 24;8(3):400-8. J Pharm Pharm Sci. 2005. PMID: 16401390 Free article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

252 results

Search Page

Filters